Hematology News

Inflammation inhibition through the interleukin-1 beta/interleukin-6 signaling pathway reduced incidence of anemia and improved hemoglobin levels among patients with anemia, according to results of an exploratory analysis of randomized trial data published in Annals of Internal Medicine.

In a retrospective cohort study, patients with atrial fibrillation who were treated with apixaban experienced lower incidence of ischemic stroke, systemic embolism and bleeding compared with patients who received rivaroxaban.

ORLANDO — More than one in 10 patients with lymphoma who underwent chimeric antigen receptor T-cell therapy developed new venous thromboembolism, according to study results presented at TCT | Transplantation & Cellular Therapy Meetings.

ORLANDO — LentiGlobin gene therapy led to substantial reductions of sickle hemoglobin and considerable improvement in key markers of hemolysis, according to updated results from the phase 1/phase 2 HGB-206 study presented at TCT | Transplantation & Cellular Therapy Meetings.

Bleeding in the lower gastrointestinal tract increased risk for incident colorectal cancer in patients with atrial fibrillation who were treated with oral anticoagulants, according to a study published in the European Heart Journal.

Eileen Smith, MD, has been appointed chair of the department of hematology and hematopoietic cell transplantation at City of Hope.

Gabriela S. Hobbs, MD, and Oluwatoyosi Adefunke Onwuemene, MD, MS, will participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program.

The FDA approved ferric derisomaltose injection for the treatment of iron deficiency anemia in adults who had an intolerance or unsatisfactory response to oral iron or who have nonhemodialysis-dependent chronic kidney disease, according to a press release from the drug’s manufacturer.

In 1984, a teenage boy was lying in his hospital bed, his body ravaged by acute graft-versus host disease.

Children with peripherally inserted central catheters demonstrated a significantly higher risk for venous thromboembolism, central line-associated bloodstream infections and catheter malfunctions than children with centrally inserted tunneled lines, according to a new analysis of data from the CIRCLE study published in Blood.